ConductScience.org, home

Paper16099596

An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.

Kim S and 19 others. Int J Radiat Oncol Biol Phys, 2005. Cited by 228 papers, by iCite.

Cite this record

ConductScience Library. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. Papers, record 16099596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16099596

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.
PubMed
Journal
Int J Radiat Oncol Biol Phys
PubMed
Year
2005
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
228
iCite
Relative citation ratio, by iCite
5.91
iCite
Revised in PubMed
2023-03-23
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kim SSung
2Lim DHDo Hoon
3Lee JJeeyun
4Kang WKWon Ki
5MacDonald JSJohn S
6Park CHChan Hyung
7Park SHSe Hoon
8Lee SHSe-Hoon
9Kim KKihyun
10Park JOJoon Oh
11Kim WSWon Seog
12Jung CWChul Won
13Park YSYoung Suk
14Im YHYoung-Hyuck
15Sohn TSTae Sung
16Noh JHJae Hyung
17Heo JSJin Seok
18Kim YIYong Il
19Park CKChul Keun
20Park KKeunchil

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Stomach NeoplasmsMajor topic
Adult
Aged
Antimetabolites, Antineoplastic
Chemotherapy, Adjuvant
Female
Fluorouracil
Gastrectomy
Humans
Leucovorin
Male
Middle Aged
Neoplasm Recurrence, Local
Prospective Studies
Radiotherapy Dosage
Radiotherapy, Adjuvant
Survival Rate

Source PubMed

Download CSV of topics

Cited by116

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 228 citations.

PMIDTitleJournalYearIn PapersSource
41625476Preoperative Chemoradiotherapy versus Chemotherapy for Locally Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma: A Phase III Randomized Controlled Trial from China.Cancer Commun (Lond)2026https://conductscience.org/library/papers/41625476PubMed
41291615Comparative study of the outcomes of robotic versus laparoscopic distal gastrectomy with hand-sewn anastomosis in Billroth-I reconstruction.BMC Surg2025https://conductscience.org/library/papers/41291615PubMed
40402361Gastric Carcinoma Patients with Advanced Pathological Lymph Node Stage Benefit from Postoperative Radiotherapy: A Retrospective Analysis.J Gastrointest Cancer2025https://conductscience.org/library/papers/40402361PubMed
40296904Classical biomarkers and non-coding RNAs associated with diagnosis and treatment in gastric cancer.Oncol Res2025https://conductscience.org/library/papers/40296904PubMed
38259276Efficacy and safety of docetaxel plus S-1-based therapy in gastric cancer: a quantitative evidence synthesis of randomized controlled trials.Front Pharmacol2023https://conductscience.org/library/papers/38259276PubMed
37959193Updated Adjuvant Chemotherapy for Gastric Cancer.J Clin Med2023https://conductscience.org/library/papers/37959193PubMed
37433916Comparative outcomes of laparoscopic and robotic approaches to gastrectomy: a National Cancer Database study.Surg Endosc2023https://conductscience.org/library/papers/37433916PubMed
36172711
alpha2,3 sialic acid processing enzymes expression in gastric cancer tissues reveals that ST3Gal3 but not Neu3 are associated with Lauren's classification, angiolymphatic invasion and histological grade.
Eur J Histochem2022https://conductscience.org/library/papers/36172711PubMed
35116800The necessity of adjuvant radiotherapy for locally advanced gastric cancer in China.Transl Cancer Res2019https://conductscience.org/library/papers/35116800PubMed
34386368Evaluating the benefit of adjuvant radiotherapy after extensive lymph node dissection for gastric cancer: a single-institute retrospective study.Tzu Chi Med J2021https://conductscience.org/library/papers/34386368PubMed
34238296Assessment of the value of adjuvant radiotherapy for treatment of gastric adenocarcinoma based on pattern of post-surgical progression.World J Surg Oncol2021https://conductscience.org/library/papers/34238296PubMed
33804024Beyond the Guidelines: The Grey Zones of the Management of Gastric Cancer. Consensus Statements from the Gastric Cancer Italian Network (GAIN).Cancers (Basel)2021https://conductscience.org/library/papers/33804024PubMed
33613554An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer.Front Immunol2020https://conductscience.org/library/papers/33613554PubMed
32259036Prognostic factors for survival in patients with gastric cancer: Single-centre experience.North Clin Istanb2020https://conductscience.org/library/papers/32259036PubMed
31939629A 21‑gene Support Vector Machine classifier and a 10‑gene risk score system constructed for patients with gastric cancer.Mol Med Rep2020https://conductscience.org/library/papers/31939629PubMed
31897342Postoperative Radiotherapy Improves Survival in Gastric Signet-Ring Cell Carcinoma: a SEER Database Analysis.J Gastric Cancer2019https://conductscience.org/library/papers/31897342PubMed
31859917ADJUVANT CHEMORADIOTHERAPY AFTER SUBTOTAL OR TOTAL GASTRECTOMY AND D2 LIMPHADENECTOMY INCREASES SURVIVAL IN ADVANCED GASTRIC CANCER?Arq Bras Cir Dig2019https://conductscience.org/library/papers/31859917PubMed
31702665Careful dose modification of apatinib as third or further-line treatment in advanced gastric cancer patients with poor performance status.Medicine (Baltimore)2019https://conductscience.org/library/papers/31702665PubMed
31558973Current status of adjuvant chemotherapy for gastric cancer.World J Gastrointest Oncol2019https://conductscience.org/library/papers/31558973PubMed
31057329False discovery rate control for high dimensional networks of quantile associations conditioning on covariates.J R Stat Soc Series B Stat Methodol2018https://conductscience.org/library/papers/31057329PubMed

See all 116 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16099596

GET https://conductscience.org/api/papers/v1/16099596/cited_by?page=2